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Phospholipids are an essential constituent part of the cells. Ethanolami-
ne phosphatine ( E P ) , sphingomyelin (SPM) , and to a lesser degree lecithin 
( L ) and serine phosphatide ( S P ) enter in the myel in composition (16). The 
metal complexes of phospholipids are mainly concentrated in the cytoplasmic 
membrane, in the mitochondrial and nuclear fraction. Le t i t h in (phospha-
tidylcholine) and phosphatidylethanolamine (70—80 per cent of the total 
amount of phospholipids) build up the basic mass in phospholipid membra-
nes. The brain membranes contain in addition phosphatidylserine (18), pho-
sphat ide acid and its polymer polyglycerophosphatide ( P G P ) . Presumably-
the permeability of nerve membranes may undergo modification owing to th, 
abi l i ty of inositol-containing phospholipids (monophosphoinositide phose 
phatide — M P I P ) to form stable complexes wi th C a 2 + through their monoes-
terified P 0 4 ~ 3 groups ( 1 , 9 ) . The exceptionally important role played by mag-
nesium phospholipids in accomplishing the numerous nerve cel l transforma-
tions is wel l known (11). Manganese whose electron configuration outlines it 
as a good chelate-producer, may participate in complex compounds wi th the 
phospholipids (5), where through C a 2 + and Mg 2 " f replacement, the biological 
properties of the compounds w i l l be altered. The latter opinion is confirmed 
by our studies since we were successful in establishing a reduction of the above 
ions 1 concentration in the brain and serum of rats under manganese effect. 
Pyridoxalphosphate ( P L P ) is a specific co-factor, promoting the activation 
of sphingomyelin synthesis in the brain (3, 17), whereas manganese exerts 
effect on the P L P content. We found a reduction of the latter in the brain, l i -
ver and blood of animals treated wi th manganese (5). 
The above findings gave us sufficient reason to surmise the occurrence 
of derangements in fat metabolism, respectively, in the concentration of pho 
spholipids under the effect of manganese. 
Material and Methods 
The study was conducted on 80 fully mature male white rats, weighing 
1 3 0 ± 15 g in the average, and distributed in groups as shown in Table 1. 
Serum phospholipids were demonstrated using the tests of Hanry , and 
in 10 per cent homogenate — according to the method of McMurray (14) as 
modified by Smirnov and co-authors (2) and Karagezyan (10) . The staining 
of dots was carried out wi th iodine vapours (15). Phospholipids in the brain 
were calculated as l ipidic P in mcg/g fresh tissue, and in the serum — in mg% 
phosphatides, resp. P . 
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T a b l e 1 
Controls 
Poisoned 
Distribution of Animals and Doses Employed 
Number of animals 








150 rag/kg M n 2 + 
per ps 10.7% solution MnClj . 2 H 2 0 
Results and discussion 
Serum and brain phospholipid concentrations are shown in Tables 2 and 3. 
T a b l e 2 




Phosphatides Lipidic phosphorus 
days 
Sx ! 
60 days 30 days 
Sx 
76.18=1=3.01 
43.60== 1.93 0.001 
101.71=1=2.89 ! 
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From Table 2 i t can be seen that serum phosphatides in the control ani-
mals show a nearly 1.3 increase wi th aging. Under manganese effect an almost 
twofold decrease is observed wi th in 30 days of introducing the noxa (53 per 
cent), and to a lesser degree wi th in 60 days (with about 34 per cent). 
In the brain and serum of the control animals a certain age related in-
crease in phospholipid concentration is also noted (with 1.08 per cent). These 
results comply wi th the data reported by Rouser and Kr i t chevsky (19). 
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Under the effect of manganese a reduction of a l l phospholipids included 
in the study is recorded, a reduction which is in direct correlation ( r ^ 0 . 9 9 ) 
wi th the duration of the experiment. W i t h i n 30 days, the total lowering amo­
unts to 21.65 per cent, and w i th in 60 days — to 34.43 per cent. A t 30 clays, 
the fall in lecithin content is the greatest (with 24.46 per cent), next ranking 
MP I P (with 23.79 per cent), without taking into consideration x- and y-pho-
spholipid reduction. The latter show the strongest decrease in either of the 
experimental periods. After 60-dav long poisoning, ihe lowest level is disp­
layed by L and M P I P (with about 40 per cent), followed by S P M (with 38.94 
per cent). 
The obtained results corroborate our hypothesis about manganese tre­
atment effect on phospholipid metabolism. Apart from formation of manga-
nochelates and reduced P L P concentration, the lowered phospholipid con­
centration may be also explained by the established decreased concentration 
of free amino acids in the brain, blood and liver of animals and humans under 
the effect of manganese (7, 8 ) . The latter presumption is in accordance wi th 
the data submitted by Karagezyan et a l (12) concerning the lowered content 
of phospholipids in the brain of fasting animals. There are reports by a num­
ber of authors (2, 4, 13) on the spli t t ing of individual phospholipids in the 
brain in cases of protein deficiency. 
Our results may be furthermore related to the substantial increase in the 
level >f fatty acids, found in the animals treated wi th manganese (6). In 
the opinion of Karagezyan (10), these acids participate in the synthesis of 
phospholipids, blood phospholipids in particular, but we feet that it is more 
l ikely that such an increase is produced by l ipid decomposition, and not by 
a regulatory mechanism. Moreover, the substantial lecithin decrease in the 
brain may be attributed to the manganese induced reduction of S-adenosyl-
methionine content (5) , indispensable in one of its synthesis routes (21). 
Hence, the results described above point to a phospholipid metabolism 
derangement in experimentally induced manganese intoxication. The study 
of phospholipid content in the serum of workers exposed to manganese effect 
is of interest, and it w i l l be the subject of further researches along this l ine. 
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Ф О С Ф О Л И П И Д Ы МОЗГА И С Ы В О Р О Т К И У К Р Ы С 
П Р И Э К С П Е Р И М Е Н Т А Л Ь Н О М В О З Д Е Й С Т В И И М А Р Г А Н Ц Е М 
Л. Халачева 
Р Е З Ю М Е 
Сообщается о понижении концентрации общих фосфолипидов в сыво-: 
ротке крови у крыс, травленных 150 мг /кг веса М п 2 + через день в продол­
жении 60 дней . В более слабой степени наблюдалось уменьшение фосфон 
липидов в мозговой ткани , что находится в прямой корреляции ( ч = 0 , 9 9 ) 
с продолжительностью т р а в л е н и я . Устанавливаются более низкие кон­
центрации лецитина , монофосфоинозит-фосфатидов и сфингомиелина. Вы­
сказываются предположения д л я объяснения в л и я н и я на фосфолипидный; 
обмен при воздействии марганцем. 
